| 今开：2.91 | 昨收：2.9 |
| 最高：2.91 | 最低：2.75 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.96850189E8 |
Codexis(CDXS)02-17 05:05
$Codexis(CDXS)$ 8-K Current report, item 5.02 Accession Number: 0001193125-24-038458 Act: 34 Size: 138 KB 网页链接查看全文
Codexis(CDXS)02-29 05:25
$Codexis(CDXS)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001200375-24-000007 Act: 34 Size: 312 KB 网页链接查看全文
Codexis(CDXS)02-10 05:15
$Codexis(CDXS)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001193125-24-029929 Act: 34 Size: 371 KB 网页链接查看全文
Codexis(CDXS)03-07 05:15
$Codexis(CDXS)$ 8-K Current report, items 4.01 and 9.01 Accession Number: 0001193125-24-060706 Act: 34 Size: 151 KB 网页链接查看全文
Codexis(CDXS)02-15 05:55
$Codexis(CDXS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-023878 Act: 34 Size: 55 KB 网页链接查看全文
Codexis(CDXS)02-09 21:55
$Codexis(CDXS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000315066-24-001039 Act: 34 Size: 8 KB 网页链接查看全文
Codexis(CDXS)02-14 05:25
$Codexis(CDXS)$ 8-K Current report, items 1.01, 2.03, 3.02, and 9.01 Accession Number: 0001193125-24-033744 Act: 34 Size: 216 KB 网页链接查看全文
Codexis(CDXS)02-29 07:06
$Codexis(CDXS)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001200375-24-000009 Act: 34 Size: 14 MB 网页链接查看全文
智通财经APP获悉，Codexis(CDXS.US)宣布它已经从葛兰素史克(GSK.US)获得了一笔与CodeEvolver蛋白质工程平台许可有关的“重大”里程碑付款。 这一里程碑标志着使用CodeEvolver平台开发的一种酶的商业化取得了进展。根据Codexis的声明，该... 网页链接
智通财经APP获悉，平安证券发布研究报告称，维持博腾股份（300363.SZ）2021-2023年EPS 0.79、1.06、1.41元的预期，看好公司能力与规模的进一步提升，维持“推荐”评级。 平安证券指出，自2018年重整旗鼓以来，公司先后与保诺科技、Codex... 网页链接
$Codexis(CDXS)$ 8-K Current report, items 4.01 and 9.01 Accession Number: 0001193125-24-060706 Act: 34 Size: 151 KB 网页链接
$Codexis(CDXS)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001200375-24-000009 Act: 34 Size: 14 MB 网页链接
$Codexis(CDXS)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001200375-24-000007 Act: 34 Size: 312 KB 网页链接
$Codexis(CDXS)$ 8-K Current report, item 5.02 Accession Number: 0001193125-24-038458 Act: 34 Size: 138 KB 网页链接
$Codexis(CDXS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-023878 Act: 34 Size: 55 KB 网页链接
$Codexis(CDXS)$ 8-K Current report, items 1.01, 2.03, 3.02, and 9.01 Accession Number: 0001193125-24-033744 Act: 34 Size: 216 KB 网页链接
$Codexis(CDXS)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001193125-24-029929 Act: 34 Size: 371 KB 网页链接
$Codexis(CDXS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000315066-24-001039 Act: 34 Size: 8 KB 网页链接
$Codexis(CDXS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-002297 Act: 34 Size: 13 KB 网页链接
$Codexis(CDXS)$ 8-K Current report, items 2.02 and 7.01 Accession Number: 0001193125-24-004882 Act: 34 Size: 152 KB 网页链接